Rasma M Bokaldere

Title: Rasma M Bokaldere: Innovator in HDAC Inhibitors

Introduction

Rasma M Bokaldere is a prominent inventor based in Riga, Latvia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit histone deacetylases (HDAC). With a total of 4 patents to her name, her work is paving the way for new therapeutic options in treating various proliferative conditions.

Latest Patents

One of her latest patents focuses on carbamic acid compounds comprising an amide linkage as HDAC inhibitors. This invention pertains to specific active carbamic acid compounds that inhibit HDAC activity. The compounds have a defined formula where A represents an aryl group, Q1 is an aryl leader group with a backbone of at least two carbon atoms, and J is an amide linkage. The patent also covers pharmaceutical compositions that include these compounds and their use in both in vitro and in vivo settings to inhibit HDAC, particularly in the context of cancer and psoriasis.

Career Highlights

Rasma M Bokaldere is associated with Topotarget UK Limited, where she continues to advance her research and development efforts. Her innovative work has garnered attention in the pharmaceutical industry, contributing to the understanding and treatment of diseases linked to HDAC activity.

Collaborations

Throughout her career, Rasma has collaborated with notable professionals in her field, including Paul W Finn and Ivars Kalvinsh. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Rasma M Bokaldere is a trailblazer in the development of HDAC inhibitors, with her innovative patents offering promising avenues for therapeutic interventions. Her contributions to pharmaceutical chemistry are noteworthy and continue to influence the field significantly.